AstraZeneca scraps £450m vaccine plant in Liverpool after Labour funding cut
- AstraZeneca has cancelled plans for a £450m vaccine manufacturing plant in Liverpool due to a cut in funding from the government, as stated by the pharmaceutical giant.
- The investment was initially announced as a 'vote of confidence' in Liverpool and the UK's life science sector, but Labour ministers offered less funding than before.
- An AstraZeneca spokesperson noted that 'Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous government's proposal.'
- The government stated that a 'change in the make-up of the investment' led to a reduced grant offer, highlighting the need for taxpayer value.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left5Leaning Right7Center6Last UpdatedBias Distribution39% Right
Bias Distribution
- 39% of the sources lean Right
39% Right
L 28%
C 33%
R 39%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
